EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Markedly elevated serum level of presepsin in agranulocytosis with hematologic malignancy: A potential prognostic factor in a single-institution retrospective study after granulocyte transfusion

Takuya Fukumi, Keiko Fujii, Wataru Kitamura iD, Kazuhiro Ikeuchi, Naomi Asano, Akira Yamamoto, Hiroki Kobayashi, Takumi Kondo iD, Keisuke Seike, Hideaki Fujiwara, Noboru Asada iD, Daisuke Ennishi und 4 weitere

Laboratory Medicine · 2025

DOI: 10.1093/labmed/lmae118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Takuya Fukumi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. Hauptthemen laut MEDLINE: Agranulocytosis, Lipopolysaccharide Receptors, Peptide Fragments, Hematologic Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society of Transfusion Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

No established criteria exist for assessing the effectiveness of granulocyte transfusion (GTX) or biomarkers for predicting fatal infections in neutropenia. This study aimed to assess whether a novel sepsis marker, presepsin (P-SEP), is a useful prognostic indicator during GTX.

Methods

We collected frozen serum from 8 patients who had undergone GTX between September 2022 and October 2023 and measured their P-SEP levels. We compared these results with clinical records and assessed the alterations before and after GTX and their association with prognosis.

Results

The post-transfusion neutrophil count increased in all cases. In 5 of 8 patients (62.5%), P-SEP levels were reduced 1 day after GTX. Pretransfusion P-SEP levels were statistically significantly lower in the group of patients who survived and overcame infection after transfusion (GTX-survived) than in the group of patients who did not survive (GTX-nonsurvived) (1493 pg/mL vs 6658 pg/mL, P =.04). Transfused cell counts and changes in P-SEP levels 1 day after GTX were better in the GTX-survived group than in the GTX-nonsurvived group, although the difference was not statistically significant.

Discussion

Presepsin is a biomarker that can be assessed in patients undergoing GTX for agranulocytosis. A clinically significant increase in P-SEP levels before GTX may indicate ineffective GTX and an unfavorable prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgranulocytosisLipopolysaccharide ReceptorsPeptide FragmentsHematologic NeoplasmsGranulocytesLeukocyte TransfusionHumansMaleRetrospective StudiesFemaleMiddle AgedPrognosisAgedBiomarkersAdult

Stichwörter der Autor:innen

biomarkergranulocyte transfusionhematologic malignancyinfectionneutropeniapresepsin

Substanzen

Lipopolysaccharide Receptorspresepsin protein, humanPeptide FragmentsBiomarkers

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Division of Transfusion and Cell therapy, Okayama University Hospital, Okayama, Japan.
  • Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Division of Clinical Laboratory, Okayama University Hospital, Okayama, Japan.
  • Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
  • Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

ORCID-Profile: Wataru Kitamura, Takumi Kondo, Noboru Asada, Fumio Otsuka

Förderung

  • Japan Society of Transfusion Medicine

Zitieren

APA

Fukumi, T., Fujii, K., Kitamura, W., Ikeuchi, K., Asano, N., Yamamoto, A., Kobayashi, H., Kondo, T., Seike, K., Fujiwara, H., Asada, N., Ennishi, D., Matsuoka, K. I., Otsuka, F., Maeda, Y., & Fujii, N. (2025). Markedly elevated serum level of presepsin in agranulocytosis with hematologic malignancy: A potential prognostic factor in a single-institution retrospective study after granulocyte transfusion. Laboratory Medicine. https://doi.org/10.1093/labmed/lmae118

Vancouver

Fukumi T, Fujii K, Kitamura W, Ikeuchi K, Asano N, Yamamoto A, et al. Markedly elevated serum level of presepsin in agranulocytosis with hematologic malignancy: A potential prognostic factor in a single-institution retrospective study after granulocyte transfusion. Laboratory Medicine. 2025. doi:10.1093/labmed/lmae118

BibTeX
@article{Fukumi2025,
  author = {Fukumi, Takuya and Fujii, Keiko and Kitamura, Wataru and Ikeuchi, Kazuhiro and Asano, Naomi and Yamamoto, Akira and Kobayashi, Hiroki and Kondo, Takumi and Seike, Keisuke and Fujiwara, Hideaki and Asada, Noboru and Ennishi, Daisuke and Matsuoka, Ken-Ichi and Otsuka, Fumio and Maeda, Yoshinobu and Fujii, Nobuharu},
  title = {Markedly elevated serum level of presepsin in agranulocytosis with hematologic malignancy: A potential prognostic factor in a single-institution retrospective study after granulocyte transfusion},
  journal = {Laboratory Medicine},
  year = {2025},
  doi = {10.1093/labmed/lmae118}
}
Kostenlos starten →